These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16363049)

  • 41. FDA notifications. Generic didanosine approved by FDA.
    AIDS Alert; 2008 Nov; 23(11):127-8. PubMed ID: 19043869
    [No Abstract]   [Full Text] [Related]  

  • 42. FDA notifications. FDA approves generic stavudine.
    AIDS Alert; 2009 Mar; 24(3):34. PubMed ID: 19441156
    [No Abstract]   [Full Text] [Related]  

  • 43. FDA notifications. FDA approves generic AZT.
    AIDS Alert; 2007 Jul; 22(7):79. PubMed ID: 17763553
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment activists meet with the FDA.
    Huff B
    GMHC Treat Issues; 2003 Nov; 17(11):10-1. PubMed ID: 14717107
    [No Abstract]   [Full Text] [Related]  

  • 45. FDA notifications. Generic emtricitabine is approved by the FDA.
    AIDS Alert; 2009 Feb; 24(2):21. PubMed ID: 19222147
    [No Abstract]   [Full Text] [Related]  

  • 46. FDA notifications. FDA approved 3 generic formulations of stavudine.
    AIDS Alert; 2009 Feb; 24(2):21. PubMed ID: 19219951
    [No Abstract]   [Full Text] [Related]  

  • 47. Dr. Zachary posts antiretroviral guidelines document on ETC website.
    Fac Notes (New Orleans La); 1999; 11(4):1,3. PubMed ID: 11810842
    [No Abstract]   [Full Text] [Related]  

  • 48. New ART adult guidelines released.
    AIDS Alert; 2009 Jan; 24(1):9-10. PubMed ID: 19209461
    [No Abstract]   [Full Text] [Related]  

  • 49. FDA notifications. FDA approves NDA for Lexiva.
    AIDS Alert; 2007 Dec; 22(12):142. PubMed ID: 18415960
    [No Abstract]   [Full Text] [Related]  

  • 50. HIV doctors on improving adherence.
    Wagner MD
    Posit Aware; 2003; 14(4):39. PubMed ID: 12951951
    [No Abstract]   [Full Text] [Related]  

  • 51. FDA notifications. FDA tentatively approves generic lamivudine.
    AIDS Alert; 2007 May; 22(5):57. PubMed ID: 17580368
    [No Abstract]   [Full Text] [Related]  

  • 52. FDA notifications. FDA published 2 new rules regarding INDs.
    AIDS Alert; 2009 Nov; 24(11):130-1. PubMed ID: 19967790
    [No Abstract]   [Full Text] [Related]  

  • 53. FDA notifications. FDA approves generic lamivudine.
    AIDS Alert; 2008 Dec; 23(12):142. PubMed ID: 19110688
    [No Abstract]   [Full Text] [Related]  

  • 54. FDA notifications. FDA approved pediatric efficacy supplement for Retrovir syrup.
    AIDS Alert; 2008 Nov; 23(11):128. PubMed ID: 19043870
    [No Abstract]   [Full Text] [Related]  

  • 55. FDA notifications. FDA's final guidance on HIV resistance testing.
    AIDS Alert; 2008 Jan; 23(1):10-1. PubMed ID: 18574867
    [No Abstract]   [Full Text] [Related]  

  • 56. FDA notifications. FDA approves label change for nevirapine.
    AIDS Alert; 2008 Aug; 23(8):91-2. PubMed ID: 18724490
    [No Abstract]   [Full Text] [Related]  

  • 57. Anti-HIV agents. New evidence changes guidelines about when to start treatment.
    TreatmentUpdate; 2009 Jan; 21(1):2-4. PubMed ID: 19248282
    [No Abstract]   [Full Text] [Related]  

  • 58. FDA notifications. FDA approval for generic lamivudine/zidovudine.
    AIDS Alert; 2008 Jan; 23(1):12. PubMed ID: 18572476
    [No Abstract]   [Full Text] [Related]  

  • 59. FDA notifications. Raltegravir indication extended for treatment-naive patients.
    AIDS Alert; 2009 Aug; 24(8):93. PubMed ID: 19705587
    [No Abstract]   [Full Text] [Related]  

  • 60. FDA notifications. Generic lamivudine tentatively approved.
    AIDS Alert; 2008 Mar; 23(3):33. PubMed ID: 18661640
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.